AGTC - アプライド・ジェネティック・テクノロジ―ズ （Applied Genetic Technologies Corporation）

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (“AGTC” or the “Company”) (Nasdaq: AGTC), announced today the successful completion of the previously announced tender offer (the “Offer”) to purchase all of the issued and outstanding shares of common stock of AGTC by a portfolio company of Syncona Limited (LON: SYNC) (“Syncona”). The Offer, as extended, expired at 5:00 p.m., Eastern Time, on November 30, 2022, and the acquisition was completed through a merger under Section 251(h) of the General Corporation Law of the State of Delaware. Pursuant to the terms of the definitive merger agreement, AGTC stockholders are entitled to receive $0.34 per share in cash at closing, plus up to an additional $0.73 per share payable pursuant to contingent value rights (CVRs) upon the achievement of specified milestones.

https://www.investing.com/news/pro/applied-genetic-technologies-said-syncona-limited-extended-offer-to-purchase-all-shares-at-034sh-432SI-2953637

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 29, 2022 -- Applied Genetic Technologies Corporation , announced today that a portfolio company of Syncona Limited has extended the expiration of its… | November 29, 2022

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 29, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (“AGTC” or the “Company”) (Nasdaq: AGTC), announced today that a portfolio company of Syncona Limited (LON: SYNC) (“Syncona”) has extended the expiration of its previously announced tender offer to purchase all of the issued and outstanding shares of AGTC common stock for $0.34 per share in cash at closing, plus up to an additional $0.73 per share payable pursuant to contingent value rights (CVRs) upon the achievement of specified milestones.

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (“AGTC” or the “Company”) (Nasdaq: AGTC), announced today the successful completion of the previously announced tender offer (the “Offer”) to purchase all of the issued and outstanding shares of common stock of AGTC by a portfolio company of Syncona Limited (LON: SYNC) (“Syncona”). The Offer, as extended, expired at 5:00 p.m., Eastern Time, on November 30, 2022, and the acquisition was completed through a merger under Section 251(h) of the General Corporation Law of the State of Delaware. Pursuant to the terms of the definitive merger agreement, AGTC stockholders are entitled to receive $0.34 per share in cash at closing, plus up to an additional $0.73 per share payable pursuant to contingent value rights (CVRs) upon the achievement of specified milestones.

https://www.investing.com/news/pro/applied-genetic-technologies-said-syncona-limited-extended-offer-to-purchase-all-shares-at-034sh-432SI-2953637

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 29, 2022 -- Applied Genetic Technologies Corporation , announced today that a portfolio company of Syncona Limited has extended the expiration of its… | November 29, 2022

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 29, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (“AGTC” or the “Company”) (Nasdaq: AGTC), announced today that a portfolio company of Syncona Limited (LON: SYNC) (“Syncona”) has extended the expiration of its previously announced tender offer to purchase all of the issued and outstanding shares of AGTC common stock for $0.34 per share in cash at closing, plus up to an additional $0.73 per share payable pursuant to contingent value rights (CVRs) upon the achievement of specified milestones.

Gainers Applied Genetic Technologies Corporation (NASDAQ: AGTC ) climbed 62.4% to close at $0.39. Syncona disclosed that it will acquire Applied Genetic Technologies Corporation. Vaxcyte, Inc. (NASDAQ: PCVX ) shares surged 60.4% to close at $33.00 on Monday after the company announced positive topline results from the Phase 1/2 clinical proof-of-concept study evaluating the safety, tolerability and immunogenicity of VAX-24. Mullen Automotive, Inc. (NASDAQ: MULN ) climbed 32.9% to close at $0.50 after the company announced it has secured exclusive sales, distribution and branding rights to the I-GO, which is fully EU Standard homologated and certified for sale in select European markets. Cyclerion Therapeutics, Inc. (NASDAQ: CYCN ) climbed 24.8% to close at $0.4741. Motus GI Holdings, Inc. (NASDAQ: MOTS ) climbed 23.1% to close at $1.97 after the company announced clinical data for Pure-Vu EVS in three poster presentations at the American College of Gastroenterology 2022 Annual Scientific Meeting.

At the close of the New York Stock Exchange, the Dow Jones rose 1.34% to a one-month high, the S&P 500 was up 1.19% and the NASDAQ Composite was up 0.86%. Amgen Inc was the top performer among the components of the Dow Jones index today, up 9.38 points or 3.72% to close at 261.32. Quotes Coca-Cola Co rose by 1.61 points (2.88%), ending trading at 57.57. Home Depot Inc rose 7.73 points or 2.81% to close at 283.26. The least gainers were Nike Inc, which lost 0.49 points or 0.55% to end the session at 88.01. The Walt Disney Company (NYSE:DIS) was up 0.32 points or 0.31% to close at 101.72, while Chevron Corp was down 0.06 points or 0.03% to end the trading at 173.13. Leading gainers among the S&P 500 index components in today''s trading were HCA Holdings Inc, which rose 7.02% to hit 210.47, Tractor Supply Company, which gained 5.30% to close at 207.83, and also shares of Regions Financial Corporation, which rose 5.28% to close the session at 20.55. The least gainers were Las Vegas Sands Corp, which shed 10.29% to close at 35.05.

U.S. stocks traded higher toward the end of trading, with the Dow Jones surging more than 450 points on Monday. The Dow traded up 1.50% to 31,547.65 while the NASDAQ rose 1.04% to 10,972.47. The S&P 500 also rose, gaining, 1.38% to 3,804.48. Also check this: Market Volatility Decreases As Dow Jumps More Than 700 Points Leading and Lagging Sectors Health care shares climbed 2.1% on Monday. Leading the sector was strength from Vaxcyte, Inc. (NASDAQ: PCVX ) and IMARA Inc. (NASDAQ: IMRA ). In trading on Monday, materials shares fell by 0.3%. Top Headline The S&P Global manufacturing PMI dropped to 49.9 in October from 52 in September, down from market estimates of 51. US services PMI fell to 46.6 in October from 49.3 in the prior month. Equities Trading UP Vaxcyte, Inc. (NASDAQ: PCVX ) shares shot up 67% to $34.29 after the company announced positive topline results from the Phase 1/2 clinical proof-of-concept study evaluating the safety, tolerability and immunogenicity of VAX-24. Shares of Applied Genetic Technologies Corporation (NASDAQ: AGTC ) got a boost, shooting 60% to $0.3845 after Syncona announced it …

Applied Genetic Technologies Corporation (AGTC)’s stock is trading at $0.38 at the moment marking a rise of 58.25% from the last session close. As of this writing, shares are priced at -88.05% less than their 52-week high of $3.18, and 64.98% over their 52-week low of $0.23. Based on the past 30-day period, the stock […]

Gainers Vaxcyte, Inc. (NASDAQ: PCVX ) shares jumped 65% to $33.96 after the company announced positive topline results from the Phase 1/2 clinical proof-of-concept study evaluating the safety, tolerability and immunogenicity of VAX-24. Healthcare Triangle, Inc. (NASDAQ: HCTI ) gained 54.8% to $0.6000. Applied Genetic Technologies Corporation (NASDAQ: AGTC ) climbed 54.1% to $0.3701. Syncona disclosed that it will acquire Applied Genetic Technologies Corporation. Motus GI Holdings, Inc. (NASDAQ: MOTS ) gained 40% to $2.2450 after the company announced clinical data for Pure-Vu EVS in three poster presentations at the American College of Gastroenterology 2022 Annual Scientific Meeting. Mullen Automotive, Inc. (NASDAQ: MULN ) rose 31.8% to $0.4957 after the company announced it has secured exclusive sales, distribution and branding rights to the I-GO, which is fully EU Standard homologated and certified for sale in select European markets. Enservco Corporation (NYSE: ENSV ) gained 21.3% to $2.4499.